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Abstract
Purpose Following lumbar fusion surgery (LFS), 40% of patients are unsure/dissatisfied with their outcome. A prospective, 
single-centre, randomised, controlled trial was conducted to evaluate the feasibility (including clinical and economic impact) 
of a theoretically informed rehabilitation programme following LFS (REFS).
Methods REFS was informed by an explicit theoretical framework and consisted of 10 consecutive weekly group rehabili-
tation sessions (education, low-tech cardiovascular, limb and spine strengthening exercises, and peer support). Participants 
were randomised to REFS or ‘usual care.’ Primary feasibility outcomes included recruitment and engagement. Secondary 
outcomes, collected preoperatively and 3, 6, and 12  months postoperatively, comprised the Oswestry disability index, 
European Quality of Life 5 dimensions score, pain self-efficacy questionnaire, hospital anxiety and depression scale and 
the aggregated functional performance time. Economic impact was evaluated with the Client Services Receipt Inventory.
Results Fifty-two of 58 eligible participants were recruited, and engagement with REFS was > 95%. REFS participants 
achieved a clinically meaningful reduction in unadjusted mean short-term disability (− 13.27 ± 13.46), which was not observed 
in the ‘usual care’ group (− 2.42 ± 12.33). This was maintained in the longer term (− 14.72% ± 13.34 vs − 7.57 ± 13.91). 
Multilevel regression analyses, adjusted for body mass index, baseline depression, and smoking status reported a statisti-
cally significant short-term improvement in disability (p = 0.014) and pain self-efficacy (p = 0.007). REFS costs £275 per 
participant.
Conclusions Results suggest that REFS is feasible and potentially affordable for delivery in the National Health Service. 
It is associated with a clinically meaningful impact. A multicentre randomised controlled study to further elucidate these 
results is warranted.
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Introduction
Lumbar fusion surgery (LFS) is commonly undertaken 
in parallel with the decompression of affected neural tis-
sue to relieve back/leg symptoms. Common indications 
include spondylolisthesis, disc disease, and stenosis [1]. 
The volume of LFS is increasing particularly in patients 
over 60 years [2]. In high income countries, the population 
of those over 60 is growing faster than any other age group 
[3]. Therefore, the increase in LFS is likely to continue, 
with patients living longer postoperatively.
Forty per cent of all patients are unsure/dissatisfied with 
their outcome following LFS [4], experiencing impaired 
psychological, social, and neuromusculoskeletal function 
[5]. Many of these reported problems appear amenable to 
rehabilitation. A recent meta-analysis demonstrated that 
‘complex’ rehabilitation (exercise combined with psycho-
logically mediated content, such as cognitive behavioural 
therapy) enhanced outcome when compared with ‘usual 
care’ [6]. However, the included studies [7], and [8], had 
methodological constraints limiting the wider extrapola-
tion of these results. Both studies commenced rehabilita-
tion within 3 weeks of LFS, potentially contributing to the 
high (22.6%) re-operation rate [7]. Other researchers have 
demonstrated inferior outcomes with rehabilitation com-
mencing before 3 months [9]. Abbott et al. [7] excluded 
participants over 65 years of age, and the ‘usual care’ 
comparator group consisted of a single session (20 min) 
of exercise-based self-management advice. This does not 
reflect current ‘usual care’ in the UK, which typically con-
sists of 6 sessions of individualised physiotherapy [10]. In 
the study by [8], the ‘psychomotor’ rehabilitation interven-
tion comprised 38 h of hospital-based, multi-professional 
rehabilitation (physiatrists, psychologists, and physiother-
apists). Whilst no economic reports were identified, it is 
plausible such a programme would prove prohibitively 
costly to deliver. Therefore, previous studies [7, 8] are not 
representative of those patients undergoing LFS in the UK.
Guidance from the Medical Research Council (MRC) 
encourages the use of theoretical modelling in the early 
development of complex healthcare interventions, such 
as rehabilitation [11]. Despite this, neither study from 
the meta-analysis was based on any explicit theoretical 
framework. Currently, no evidence-based ‘gold standard’ 
rehabilitation regime exists following LFS. To our knowl-
edge, no study has compared a theoretically informed 
rehabilitation programme with current UK ‘usual care’ 
(individual physiotherapy). To bridge this research gap, 
there is an urgent need to develop and evaluate a rehabili-
tation programme that is acceptable to participants, safe, 
and affordable for use following LFS [6].
The design and evaluation of the rehabilitation pro-
gramme in this study, rehabilitation following lumbar fusion 
surgery (REFS), was guided by the checklist for group-based 
behavioural change interventions [12] and the Consolidated 
Standards of Reporting Trials and extension for non-phar-
macological trials (CONSORT) [13].
The primary aim of the study was to evaluate the feasi-
bility of delivering the REFS programme following techni-
cally successful LFS. The secondary aim was to describe 




This was a prospective, single-centre, randomised controlled 
feasibility study. In keeping with MRC guidance [11], a 
theoretical framework was developed to inform the content 
and delivery aspects of REFS using the behavioural change 
wheel methodology [14] and social cognitive theory (SCT) 
[15]. The resulting hypothetical causal pathway (Fig. 1) and 
REFS programme are presented (Fig. 2). The study was 
approved by the National Research Ethics Service (NRES) 
at Queen Square on the 14th June 2014 (14/LO/0748) and 
registered, ISRCTN60891364.
Participants
A convenience sample (n = 52) of participants was recruited 
between August 2014 and April 2016. Potential participants 
were identified from the neurosurgical waiting list, screened 
for eligibility, sent a patient information sheet, and were met 
preoperatively to discuss participation. Those willing to 
enrol in the study provided signed consent and baseline data.
Participants were considered eligible if they were aged 
18–75 years and undergoing primary LFS (1–3 inter-verte-
bral levels) for degenerative/congenital conditions. Partici-
pants were excluded if they had previously undergone LFS 
(prior laminectomy/discectomy were eligible); had spinal 
cord involvement; lower limb joint pain precluding assess-
ment; could walk less than 20 metres on flat ground; had 
poorly controlled psychological/medical comorbidity limit-
ing engagement with rehabilitation; inadequate verbal and 
written English language skills; or were unwilling/unable to 
undertake exercise, attend REFS or provide consent. Block 
randomisation was employed (Sealed Envelope Ltd, https ://
www.seale denve lope.com, accessed 22/6/2014) (REFS or 
‘usual care’). Codes were generated at the remote host Uni-
versity site and placed into sequentially numbered opaque 
envelopes to preserve blinding of allocation. The nature 
of the intervention prevents the blinding of participants, 
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who were informed of their allocation. Data collection and 
study physiotherapists were not blinded to allocation. As 
the majority of outcome measures were self-reported, this 
potential source of bias was unlikely to have significantly 
impacted the results.
Following recruitment and baseline data collection, par-
ticipants underwent LFS and returned for clinical review 
and face-to-face data collection at 3, 6, and 12 months post-
surgery. Continued eligibility was re-evaluated at 3 months 
against a priori criteria (e.g., infection, loosening of the 
metalware). Those participants with evidence of surgical 
complication were excluded. Missing data were treated as 
per protocol, a case wise deletion of the relevant variable 
and time point, which is acceptable when the data are miss-
ing at random. Recruitment, data collection, and all surgery 
occurred at a tertiary neurosurgical hospital.
Outcome measures
Background and anthropometric data were collected by self-
report and corroboration with hospital records as required. 
Height in centimetres and weight in kilograms were meas-
ured at pre-assessment clinic with standard equipment.
Primary outcomes (feasibility evaluation)
Based on MRC guidance [11], the feasibility evaluation 
recorded; total LFS operations performed during the recruit-
ment phase; number of eligible patients (with reasons for 
ineligibility); recruitment (with reasons for refusal); accept-
ability and characteristics of outcome measures; follow-up 
rates (with reasons for attrition); engagement with REFS 
(defined as attending ≥ 50% sessions, weekly home exercise 
records, and progressive exercise achievement).
Secondary outcomes (clinical and economic evaluation)
The clinical and economic impact of REFS were evaluated 
with selected quantitative measures: Oswestry Disability 
Index, version 2 (ODI) [16], a widely used self-reported 
measure of back related disability; pain self-efficacy ques-
tionnaire (PSEQ) [17], evaluating participants confidence 
in their ability to perform tasks despite pain; hospital 
Fig. 1  Hypothetical causal pathway informing the development of the REFS programme
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anxiety and depression scale (HADS) [18], a measure of 
hospital-related anxiety and depression; European Quality 
of Life 5 Dimensions Score (EQ-5D-5L) [19], a measure 
of health status across a range of indicators; aggregated 
functional performance time (AFPT) [20], the aggregated 
time in seconds for a participant to walk 50 yards, sit-to-
stand and walk 50 yards, and climb and descend a flight of 
12 stairs. A ‘nested’ economic evaluation (REFS n = 10, 
‘usual care’ n = 10) was conducted over the 12-month 
study period employing the Client Services Receipt Inven-
tory (CSRI) [21], a structured researcher-led interview 
collating relevant economic data, modified for use fol-
lowing LFS.
Study intervention
All participants received standard hospital-based postopera-
tive care irrespective of group allocation (mobility assess-
ment, anti-thrombotic exercises, check X-rays, and general 
medical/nursing care). Postoperative advice was provided 
to all participants, to be followed between discharge and 
the 3-month review; lift nothing heavier than a full kettle 
Fig. 2  The REFS programme
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and progress outdoor walking (< 2 miles/day) commensurate 
with pain. Participants were discharged when the surgical 
team considered it safe to do so.
REFS programme
The REFS programme was delivered at a central London 
hospital by senior physiotherapists (band 7/8) who received 
3-h training in the delivery of REFS (intervention manual 
available from corresponding author). The programme con-
sisted of 10 consecutive weekly, group (n ≤ 8) rehabilita-
tion sessions (< 90 min duration). Considered deviations in 
the delivery of REFS were permitted to meet the specific 
requirements of individual participants, for example those 
with coexisting shoulder pathology were provided alter-
natives to the shoulder raise. Participants were provided 
with an exercise diary to set goals and record their activity/
adverse reactions to exercise, and an exercise sheet to facili-
tate home exercise.
Each session commenced with education (< 20 min), com-
prising of 5 predetermined topics, commencing with topic 
1 (week 1) progressing to topic 5 (week 5). Each session 
commenced by briefly revisiting the topic(s) from previous 
week(s), thereby building the educational content throughout 
the programme. Following week 5, each topic was revisited 
to help participants apply the early learned principles into 
functional settings. Education was followed by supervised 
exercise (< 60 min), comprising of ‘low-tech’ cardiovascular, 
range of movement, and limb and spine strengthening exer-
cises. Conceptually, weeks 1–3 were considered the famil-
iarisation phase and weeks 4–10 the progressive exercise 
phase. Each session concluded with a peer support discussion 
Fig. 3  Consort flow diagram for 
REFS study
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(< 15 min) to highlight common problems and identify solu-
tions through shared experience (Fig. 2).
Usual care
‘Usual care’ consisted of referral for local individual physi-
otherapy, commonly comprising 6 sessions (30 min) of 
face-to-face physiotherapy including individualised exer-
cise-based self-management [10].
Statistical analyses
Statistical analyses were performed using Stata software 
(StataCorp LP. 2015. Stata Statistical Software: Release 14. 
College Station, TX). All tests were two-sided and assessed 
statistical significance at the p < 0.05 level. Outcome dis-
tributions were checked to ensure parametric assumptions 
were met.
Results
Participants (n = 52) were recruited from 58 eligible 
patients. A consort flow diagram is provided reporting pri-
mary study aims including recruitment, retention, and data 
capture (Fig. 3). The reasons for exclusion (progressive 
neurological disorder n = 2, severe osteoporosis, scoliosis, 
cerebral palsy, myelopathy n = 2, intrinsic cord lesion, and 
malignancy) appeared related to the neurological special-
ism of the recruiting site. Background participant data are 
presented (Table 1). Of the 19 participants randomised 
to REFS, 18 (95%) engaged with the programme (mean 
attendance 8.6 sessions). There was no crossover between 
groups.
Data capture was high (> 95%) for self-report outcomes, 
and aligning data collection with surgical follow-up may 
have enhanced this. Data capture for physical testing was 
inadequate at all follow-up time points for ‘usual care’ par-
ticipants, for example at 12 months 34.8% of participants 
were unwilling/unable to undergo physical testing (AFPT) 
compared to 5.6% of REFS participants. This was pri-
marily a consequence of ongoing pain/impaired mobility, 
those unwilling/unable to complete the AFPT had a higher 
mean (SD) disability (ODI) than those able to undertake 
physical testing (57.42 ± 15.33 vs 28.17 ± 21.45).
Secondary study aims relate to the clinical and economic 
impact of REFS. No significant difference existed between 
groups at baseline although there were more smokers (22.2% 
vs 12%) and participants with primary disc disease (37% vs 
12%) in the ‘usual care’ group (Table 2). A minimal clini-
cally important difference (MCID) of 10% has been reported 
for the ODI [22]. Therefore, REFS participants achieved a 
short-term unadjusted MCID (− 13.27% ± 13.46), which was 
not observed in the ‘usual care’ group (− 2.42% ± 12.33). 
This was maintained in the longer term (− 14.72% ± 13.34 
vs − 7.57% ± 13.91) (Table 3).
Between-group evaluation was conducted with mul-
tilevel regression analyses, adjusted for smoking status 
(p = 0.001), body mass index (p = 0.883), and baseline 
Table 1  Baseline participant characteristics on study entry
Data are mean ± SD or n ± (%)
Variable REFS group (n = 25) Usual care (n = 27)
Gender n = female (%) 19/25 (54.3%) 16/27
(59.3%)
BMI 28.26 ± 7.39 27.33 ± 3.53
Age 55.9 ± 13.5 52.6 ± 13.6
Symptom duration in 
months
100.8 ± 87.0 140.6 ± 165.8











Employed (ft + pt) 11 (44%) 11 (41%)
Home maker 2 (8%) 1 (4%)
Benefits, ill health 7 (28%) 10 (37%)
Retired 5 (20%) 5 (18%)
Diagnosis
Primary disc disease 3 (12%) 10 (37%)
Secondary disc disease 6 (24%) 5 (19%)
Lytic spondylolisthesis 3 (12%) 5 (19%)
Degenerative canal 
stenosis
13 (52%) 7 (26%)




Mean levels fused 1.28 ± 0.61 1.29 ± 0.6
Table 2  Descriptive baseline statistics by group
Variable REFS mean ± SD 
(n = 25)
‘Usual care’ 
mean ± SD 
(n = 27)
p value t test
ODI 49.6 ± 15.42 55.32 ± 18.24 p = 0.238
EQ5D VAS 50.42 ± 18.16 43.85 ± 20.9 p = 0.243
EQ5D index 0.5133 ± 0.2715 0.3557 ± 0.3306 p = 0.071
HADS (a) 10.64 ± 4.33 9.54 ± 4.46 p = 0.375
HADS (d) 8.72 ± 4.94 9.19 ± 4.21 p = 0.715
PSEQ 27.64 ± 14.92 24.23 ± 14.37 p = 0.409
AFPT 90.33 ± 49.11 107.32 ± 60.74 p = 0.362
741European Spine Journal (2019) 28:735–744 
1 3
depression (p < 0.001) R2 = 59.7% for all outcome meas-
ures from baseline (preoperative)—3 months, 3–6 months 
(short-term post-rehabilitation), and 3–12 months (long-
term post-rehabilitation) (Table 3). Participants allocated 
to REFS achieved statistically significant improvements in 
short-term adjusted mean disability (p = 0.014) and pain 
self-efficacy (p = 0.007). Short (6-month) and longer-term 
(12-month) effect sizes (95% CI) for disability (ODI) for 
were calculated for REFS 0.63 (− 0.03 to − 1.28) and 0.69 
(0.24 to − 1.35) and ‘usual care’ − 0.02 (− 0.63 to − 0.57) 
and 0.15 (− 0.43 to − 0.75). Therefore, REFS achieved a 
medium effect (d > 0.50) in both short- and longer-term 
disability, which was not evident in the ‘usual care’ group.
Evidence was also observed of nonsignificant, but poten-
tially important, improvements in quality of life and physical 
function at all postoperative time points favouring REFS 
over ‘usual care’ (Fig. 4).
Economic evaluation employed linear regression analy-
ses, by group and baseline costs, with bootstrapping to 
account for the skewed distribution of cost data, for calcu-
lation of QALY’s. Total QALYs in the REFS group were 
higher than the ‘usual care’ group after adjustment for base-
line differences in EQ5D-5L scores, revealing an adjusted 
mean (SD) difference of 0.03 (± 0.064), p = 0.637. There-
fore, REFS provided 0.03 more QALYs at an additional cost 
of £92 per patient. The indicative cost per QALY was £3067, 
below the NICE threshold of £20–£30,000. Disaggregated 
unadjusted mean costs (£) by group are provided (supple-
mental material).
Discussion
This is the first study to compare the feasibility of deliv-
ering a theoretically informed rehabilitation programme, 
REFS, with ‘usual care’ (individualised physiotherapy) 
following technically successful LFS. Primary outcomes 
reporting the feasibility of REFS were encouraging, 
including recruitment (n = 52/58) and retention (> 95%) of 
eligible participants, posing little threat to internal valid-
ity. Engagement has been described as a co-constructed 
process of participation, contribution, retention, and 
attendance [23]. Applying these criteria, 95% of partici-
pants engaged with REFS.
Ineligibility appeared related to the neurological special-
ism of the hospital, and future studies should include ortho-
paedic and neurosurgical spine units.
Feasibility studies should not focus on extensive between-
group analyses in unpowered samples. However, the secondary 
study aims, related to clinical impact, suggest REFS achieved 
clinically meaningful improvements in short- and longer-term 
disability, which reached statistical significance in the short 
term (p = 0.014). The short- and longer-term effect sizes for 
REFS participants (0.63 and 0.69, respectively) were compara-
ble to those of Abbott et al. [7] (0.56 and 0.58) but smaller than 
those reported by Monticone et al. [8] (1.13 and 1.08). This is 
potentially justified as the report by Monticone et al. included 
the combined surgical and rehabilitation effects.
The observed improvements demonstrated in the cur-
rent study are likely to be attributable to the content and 
delivery of REFS, which was designed to reduce disabil-
ity through enhanced self-efficacy. This substantiates the 
social cognitive theory [15] as the overarching programme 
theory, in which self-efficacy is afforded primacy. However, 
by 12 months the pain self-efficacy scores between groups 
had converged. It is plausible that enhanced self-efficacy 
may be a group-mediated effect, which Bandura described as 
the collective efficacy of group interventions [24]. A recent 
similar study in which rehabilitation was delivered individu-
ally as opposed to a group setting demonstrated no signifi-
cant between-group differences [25]. This finding potentially 
reinforces the critical relevance of the group effect. A pro-
cess evaluation, including a nested qualitative evaluation of 
participants experience of REFS, is currently underway to 
Table 3  Unadjusted mean ± SD change from baseline—3 month, 3–6 months, and 3–12 months with adjusted between-group p values
a Multilevel regression for depression, smoking status, and body mass index
*Statistically significant p < 0.05










Unadjusted mean change 3–12 months Between-
group 
adjusted p 
 valuesaREFS Usual care REFS Usual care REFS Usual care
ODI − 4.0 ± 16.59 − 11.42 ± 19.99 p = 0.19 − 13.27 ± 13.46 − 2.42 ± 12.33 p = 0.014 * − 14.72 ± 13.34 − 7.57 ± 13.91 p = 0.101
EQ5D VAS 12.72 ± 21.59 19.55 ± 22.0 p = 0.45 6.16 ± 17.51 − 2.68 ± 16.47 p = 0.062 6.72 ± 14.84 − 1.76 ± 18.01 p = 0.106
EQ5D index 0.1274 ± 0.2818 0.2082 ± 0.2796 p = 0.29 0.0628 ± 0.1310 − 0.0177 ± 0.131 p = 0.121 0.0214 ± 0.1683 − 0.0211 ± 0.1799 p = 0.402
HADS (a) − 1.84 ± 3.56 − 1.9 ± 2.91 p = 0.968 0.61 ± 4.19 0.05 ± 3.15 p = 0.386 − 0.38 ± 4.34 0.42 ± 3.18 p = 0.432
HADS (d) − 2.68 ± 4.89 − 1.76 ± 4.1 p = 0.41 − 0.55 ± 4.55 1.21 ± 2.95 p = 0.394 − 0.38 ± 5.11 − 0.04 ± 2.37 p = 0.952
PSEQ 3.26 ± 18.28 9.42 ± 12.86 p = 0.177 8.35 ± 10.78 − 0.55 ± 13.33 p = 0.007 * 4.66 ± 12.08 2.66 ± 9.35 p = 0.49
AFPT − 23.7 ± 53.96 4.25 ± 15.88 p = 0.1 − 19.37 ± 29.05 − 7.75 ± 25.41 p = 0.62 − 17.90 ± 37.29 − 27.22 ± 33.03 p = 0.492
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highlight valued content and explore the divergent numeri-
cal outcomes.
The REFS programme can be delivered in uni-profes-
sional settings by experienced physiotherapists with mini-
mal extra training and appears affordable, with sensitivity 
analysis where half the participants are not allocated to 
another treatment arm, suggesting a total cost of £137.50 
per participant.
Study limitations
The study findings were limited by sample size, the single-
centre design, and the reporting of ‘usual care.’ Readers 
should consider these aspects when interpreting the results. 
Data capture for physical testing (AFPT) was incomplete, 
introducing selection bias. A new mechanism for the evalua-
tion of physical performance is required; the 6-min walk test 
and sit-to-stand 30 are proposed as performance rather than 
Fig. 4  Adjusted mean with 95% CI’s for each variable by group
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time becomes the dependant variable, potentially increasing 
acceptability.
The current study had 9 dropouts at 3 months, primar-
ily due to technical surgical concerns, e.g., wound infec-
tion. Whilst it may appear preferable to defer recruitment 
until a satisfactory 3-month surgical review, this would 
result in a loss of critical preoperative data. Therefore, this 
surgical attrition should be included in future sample size 
calculations.
Conclusion
In conclusion, this study suggests that REFS provides a fea-
sible and affordable alternative to current ‘usual care.’ The 
REFS programme appears to convey a meaningful clinical 
improvement in functional ability. This improvement may 
be mediated by a group effect, which enhanced short-term 
self-efficacy. To adequately power a future efficacy study 
(assuming a two-sided significance of 5%, 90% power, a 
mean clinically important difference in disability between 
groups of 10%, and a standard deviation of ± 17.02, derived 
from this study), two groups of n = 62 participants would 
be required. Allowing for a 20% rate of attrition, this would 
equate to a sample of n = 155. Such a study should include 
participants undergoing primary and revision fusion surgery, 
have no upper age limit, and include a more acceptable eval-
uation of physical performance.
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